| Literature DB >> 28389112 |
Murat Bozdag1, Ahmed Mahmoud Alafeefy2, Abdul Malik Altamimi3, Fabrizio Carta4, Claudiu T Supuran5, Daniela Vullo6.
Abstract
We report a series of novel metanilamide-based derivatives 3a-q bearing the 2-mercapto-4-oxo-4H-quinazolin-3-yl moiety as tail. All compounds were synthesized by means of straightforward condensation procedures and were investigated in vitro for their inhibition potency against the human (h) carbonic anhydrase (CA; EC 4.2.1.1.1) isoforms I, II, IX and XII. Among all compounds tested the 6-iodo 3g and the 7-fluoro 3i derivatives were the most potent inhibitors against the tumor associated CA IX and XII isoform (KIs 1.5 and 2.7nM respectively for the hCA IX and KIs 0.57 and 1.9nM respectively for the hCA XII). The kinetic data reported here strongly support compounds of this type for their future development as radiotracers in tumor pathologies which are strictly dependent on the enzymatic activity of the hCA IX and XII isoforms.Entities:
Keywords: Carbonic anhydrase inhibitors (CAIs); Imaging; Quinazolines; Tumors
Mesh:
Substances:
Year: 2017 PMID: 28389112 DOI: 10.1016/j.bmc.2017.03.054
Source DB: PubMed Journal: Bioorg Med Chem ISSN: 0968-0896 Impact factor: 3.641